Harrow, Inc. stock gains as market cap nears USD 1.2 billion

Harrow, Inc. stock (ISIN US4158581094) is trading with a solid valuation backdrop, with the ophthalmic pharmaceutical company’s market capitalization reported at about USD 1.22 billion as of September 2026 according to CompaniesMarketCap.

Market cap and recent trading levels

According to CompaniesMarketCap, Harrow, Inc. had a market cap of USD 1.22 billion in 2026, making it roughly the 5,943rd most valuable company globally by this metric, while the same overview notes that on September 20, 2026 Nasdaq data put the figure at around USD 1.24 billion, highlighting a modest decline of about USD 0.02 billion over that short interval.

Price-oriented portals show that Harrow, Inc. shares trade on Nasdaq under the ticker HROW, with TradingView indicating a recent price of about USD 34.43 and a daily percentage increase of 3.67 percent over the preceding 24 hours, pointing to a mid-single-digit intraday gain as of its latest update in September 2026 according to TradingView.

52-week range and longer-term performance

For investors assessing where Harrow, Inc. stock currently sits in its recent trading corridor, Yahoo Finance data compiled in 2026 show a 52-week price range between USD 7.60 and USD 54.31, meaning that a mid-USD 30s quote leaves the shares clearly above the lower end of that band while still materially below the 52-week high, underscoring both the recovery from earlier lows and the remaining upside room relative to the recent peak according to Yahoo Finance.

TradingView’s performance summary adds that Harrow, Inc. stock has risen 10.89 percent over the latest week and 9.27 percent over the past month, while the one-year change stands at 9.37 percent, so the recent mid-single-digit daily move is layered onto double-digit percentage gains over shorter horizons and a high-single-digit advance over the last twelve months according to TradingView.

Valuation context and volatility profile

From a valuation and risk perspective, TradingView reports that Harrow, Inc. shares carry a volatility measure of 7.35 and a beta of 2.11, indicating that the stock tends to move more sharply than the broader market and is sensitive to sentiment shifts in growth and healthcare names according to TradingView.

Analyst expectations compiled by TradingView point to a wide range of potential outcomes, with the maximum 12-month target price cited at USD 76.00 and the minimum at USD 42.00, implying that the most optimistic scenario would nearly double a mid-USD 30s quote, while the lower bound still sits above that recent level and suggests a view that the current price does not fully capture the company’s earnings power according to TradingView.

Stock positioning for retail investors

With Harrow, Inc. stock trading notably above its 52-week low of USD 7.60 but still below the 52-week high of USD 54.31, the current price region leaves room for both upside and downside moves and makes the shares a candidate for investors who can tolerate elevated volatility in exchange for potential growth in the ophthalmic therapies market according to the range data cited by Yahoo Finance.

Against the backdrop of a Nasdaq Composite that recently set record highs in September 2026 driven by strong interest in technology and growth shares, Harrow, Inc. participates in this environment with its own mid-single-digit daily price gains layered on a market capitalization around USD 1.22 billion, positioning the company in the small-cap growth segment where news on product launches, reimbursement and regulatory milestones can quickly translate into price swings according to the broader market commentary from Seoul Economic Daily.

Price as of the latest session

Per recent Nasdaq-oriented portal data, Harrow, Inc. stock was last indicated around USD 34.43 on Nasdaq in September 2026, with that level representing a 3.67 percent increase over the prior 24-hour period and leaving the shares below the 52-week high of USD 54.31 but substantially above the 52-week low of USD 7.60, while the company’s market capitalization was reported near USD 1.22 billion as of September 2026.

More news and analyses on Harrow, Inc. stock